Stanley W. Crosley

Stanley W. Crosley has over 20 years of applied experience in law, data governance and data strategy across a broad sector of the economy, including from inside multinational corporations, academia, large law firm and boutique practices, not-for-profit advocacy organizations, and governmental agencies, and is the Co-Director of the Indiana University Center for Law, Ethics, and Applied Research in Health Information (CLEAR), is Counsel to the law firm of Drinker Biddle & Reath in Washington, DC, and Principal of Crosley Law Offices, LLC.  Stan is a Senior Strategist at the Information Accountability Foundation and a Senior Fellow at the Future of Privacy Forum, where he leads health policy efforts.  He is an Adjunct Professor of Law at Maurer School of Law, Indiana University and lectures on global privacy and data protection, health privacy, and data strategy.

Stan has served as the 2014-2016 Co-Chair of the federal Privacy and Security Workgroup for Health and Human Services Office of the National Coordinator for Health Information Technology (HHS/ONCHIT) providing guidance on health privacy and data security to HHS and the White House.  Stan also serves on the board of The Privacy Projects, and as the Co-Chair of the Research Committee for C-Change.  Stan is the former Chief Privacy Officer for Eli Lilly and Company and is a former board member of the International Association of Privacy Professionals (IAPP), the International Pharmaceutical Privacy Consortium, the Indiana Health Informatics Technology, Inc., served on the IOM HIPAA and Research Workgroup that delivered the first report on the research implications of HIPAA and the Brookings Institute workgroup providing guidance on the FDA’s Sentinel project.

In his global legal practice, and in his activity as a speaker/lecturer, Stan provides thought leadership and practical guidance on topics ranging from the full spectrum of health data issues, applied and innovative technology, and privacy to data strategy and applied data ethics working with a network of regulators from the US, EU and every region of the world and peers in multinational companies and start-ups in the technology, biopharma, medical device, biotech, communications, social media, and health provider industries.